Welcome to our dedicated page for Stonex Group SEC filings (Ticker: SNEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for StoneX Group Inc. (NASDAQ: SNEX), a Fortune 50 global financial services company. Through these filings, investors can review StoneX’s official disclosures on results of operations, financial condition, capital structure, acquisitions, and other material events.
StoneX’s current reports on Form 8-K cover a range of topics. Some filings report quarterly and annual financial results, referencing press releases that detail operating revenues, net income, segment performance, and key operating metrics such as listed derivatives contract volumes, OTC derivatives volumes, securities average daily volume, FX/CFD activity, payments volumes, and interest and fees earned on client balances. Other 8-Ks describe significant corporate transactions, including the acquisition of RTS Investor Corp., parent of the R.J. O’Brien global business, and related financing arrangements.
Filings also document StoneX’s entry into material definitive agreements, such as the Indenture governing senior secured notes due 2032 issued by a wholly owned subsidiary in connection with the R.J. O’Brien acquisition. These documents outline terms including maturity, interest rate, redemption provisions, guarantees, collateral, and covenants that affect StoneX’s capital structure and obligations. Additional 8-Ks discuss share repurchase authorizations approved by the Board of Directors and prospectus supplements registering the resale of common stock issued as acquisition consideration.
On Stock Titan, StoneX filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries help explain the significance of lengthy documents such as annual reports on Form 10-K and quarterly reports on Form 10-Q, highlighting segment results, revenue composition, and risk factors. For current reports on Form 8-K, AI analysis can surface key items, including acquisitions, debt offerings, stock repurchase plans, and earnings releases.
Investors can also use this page to track insider and equity-related disclosures when available, such as unregistered sales of equity securities reported in 8-Ks, and to understand how StoneX structures its financing and manages regulatory requirements. By combining raw filings with AI-generated insights, this page is intended to make StoneX’s regulatory reporting more accessible to both professional and individual investors.
StoneX Group Inc. (SNEX) director Dhamu R. Thamodaran reported an equity award. On 10/31/2025, he acquired 118 restricted shares of common stock at $0 under the Company’s Restricted Stock Program. Following this grant, he beneficially owns 36,687 shares in direct ownership.
The award is scheduled to vest in equal installments on the anniversary dates over three years, aligning compensation with continued service on the board.
StoneX Group Inc. (SNEX) Chairman and Director John Radziwill reported acquiring 182 restricted shares of common stock on 10/31/2025 at $0 under the company’s Restricted Stock Program.
The grant vests equally on the anniversary in years one, two, and three. Following the transaction, beneficial ownership stands at 100,596 shares direct and 955,158 shares indirect through Basic Management Company Inc.
StoneX Group Inc. (SNEX) reported an insider’s initial holdings. APAC Operations CEO Gregory Kallinikos filed a Form 3 for an event on 10/31/2025.
He beneficially owns 9,000 shares of common stock (direct). He also holds stock options covering 180,000 shares at an exercise price of $83.8, first exercisable on 12/05/2026 and expiring on 12/05/2031. The Board approved the grant on June 4, 2025, with vesting in equal tranches over five years.
StoneX Group Inc. filed a prospectus supplement to its existing shelf registration statement, registering the resale by certain selling stockholders of up to 3,085,554 shares of its common stock. These shares may be sold by the selling stockholders under the Securities Act of 1933, but the company will not receive any proceeds from their sale. The filing also includes a legal opinion from Davis Polk & Wardwell LLP regarding the validity of the registered shares.
StoneX Group Inc. filed a prospectus supplement describing an offering in which selling stockholders may sell up to 3,085,554 shares as part of a total outstanding common stock count of 52,173,843 shares after the offering. The prospectus states the selling stockholders will receive all sale proceeds and that StoneX will not receive any proceeds from those sales. It lists specific selling holders (including RJO Lenders LLC with 305,179 shares and BofA Securities, Inc. with 111,640 shares) and notes the company’s common stock trades on NASDAQ under SNEX. The document also summarizes terms for debt, warrants, preferred stock, units and events of default as disclosed in the registration materials.
Sean M. O'Connor, Executive Vice-Chairman and Director of StoneX Group Inc. (SNEX), reported two open-market sales of common stock: 3,000 shares sold on 08/19/2025 at $95.00 and 2,000 shares sold on 08/20/2025 at $96.50. After the 08/19 sale he beneficially owned 134,902 shares (indirect, by trust) and after the 08/20 sale he beneficially owned 132,902 shares (indirect, by trust). The filing also shows he beneficially owns 1,019,667 shares directly and 1,695,976 shares indirectly via Darseaker Limited. No derivative transactions were reported.
StoneX Group Inc. (SNEX) Form 144 notifies the market that an insider intends to sell common stock through a broker. The filing shows 2,000 shares offered via Merrill Lynch with an aggregate market value of $193,000, against 52,164,564 shares outstanding, implying the offering is a very small fraction of total shares. The securities were originally acquired by Sean M O'Connor on 04/24/2009 in a private placement from the company; payment was cash. The filing also reports a recent sale of 3,000 shares by the Sean M O'Connor Family Trust for $284,700. The signer certifies no undisclosed material adverse information.
Form 144 notice filed for StoneX Group Inc. (SNEX) indicating a proposed sale of common stock by Sean M O'Connor, who acquired the shares in a 2009 private placement from the company. The notice lists 3,000 shares to be sold through Merrill Lynch with an aggregate market value of $284,700 and an approximate sale date of 08/19/2025. Total shares outstanding are reported as 52,164,564, and the filer reports nothing to report for securities sold in the past three months. The acquisition record shows Mr. O'Connor originally received 44,831 shares on 04/24/2009 in a private placement and paid cash.
StoneX Group Inc. has authorized a new stock repurchase program for fiscal year 2026, allowing the company to buy back up to 2.25 million shares of its outstanding common stock. The purchases may be made from time to time in open market trades or private transactions between October 1, 2025 and September 30, 2026, at the discretion of senior management and subject to market conditions and applicable legal, regulatory and contractual limits.
The company also notes that its existing authorization, approved on August 28, 2024, permitting repurchases of up to 1.5 million shares, will expire on September 30, 2025. Together, these programs give StoneX flexibility over two consecutive periods to reduce its share count when management believes conditions are appropriate.
StoneX Group Inc. filed a Form 13F reporting $2,057,334,007 in recordable holdings across 869 positions. The filing lists 3 other included managers and was signed by John Calvano, CCO, on 08-13-2025.
This Form 13F is a routine institutional holdings report summarizing the manager's long equity positions as of the reporting period and the aggregate market value disclosed in the filing.